Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.28 HKD | -3.70% | +2.39% | -33.70% |
Apr. 30 | Cutia Therapeutics' Unit Receives Jiangsu Drug Manufacturing Certificate | MT |
Apr. 30 | Cutia Therapeutics Submits NDA for Androgenetic Alopecia Treatment Spray; Shares Jump 6% | MT |
Sales 2024 * | 282M 38.9M 304M | Sales 2025 * | 487M 67.32M 526M | Capitalization | 2.06B 284M 2.22B |
---|---|---|---|---|---|
Net income 2024 * | -486M -67.12M -524M | Net income 2025 * | -385M -53.17M -415M | EV / Sales 2024 * | 8.1 x |
Net Debt 2024 * | 223M 30.8M 240M | Net Debt 2025 * | 82.84M 11.44M 89.33M | EV / Sales 2025 * | 4.39 x |
P/E ratio 2024 * |
-4.23
x | P/E ratio 2025 * |
-5.34
x | Employees | 298 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.13% |
1 day | -3.70% | ||
1 week | +2.39% | ||
Current month | -0.55% | ||
1 month | +7.53% | ||
3 months | +16.67% | ||
6 months | -63.49% | ||
Current year | -33.70% |
Managers | Title | Age | Since |
---|---|---|---|
Le Le Zhang
FOU | Founder | 46 | 19-05-14 |
Yu Qing Huang
DFI | Director of Finance/CFO | 34 | 21-05-09 |
Lei Lei
CTO | Chief Tech/Sci/R&D Officer | 40 | 20-01-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tak Yan Tao
BRD | Director/Board Member | 48 | 23-05-31 |
Lian Yong Chen
CHM | Chairman | 62 | 19-08-22 |
Ming Kit Chung
BRD | Director/Board Member | 46 | 23-06-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 7.28 | -3.70% | 701,600 |
24-05-22 | 7.56 | -0.53% | 548,200 |
24-05-21 | 7.6 | -1.30% | 557,000 |
24-05-20 | 7.7 | +4.76% | 799,600 |
24-05-17 | 7.35 | +3.38% | 720,200 |
Delayed Quote Hong Kong S.E., May 23, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.70% | 295M | |
+38.69% | 723B | |
+34.28% | 595B | |
-4.49% | 369B | |
+20.24% | 332B | |
+2.12% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.35% | 168B |
- Stock Market
- Equities
- 2487 Stock